The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
The 10th International Electronic Conference on Medicinal Chemistry & The 2nd Electronic Conference on Pharmaceutics
Part of the International Electronic Conference on Pharmaceutics series
Part of the International Electronic Conference on Medicinal Chemistry series
Event's Timezone: Central European Time
21 September 2025
5 October 2025
31 October 2025
Pharmacokinetics, Pharmacodynamics, Drug Candidates, Radiopharmaceutical Sciences, Biomolecules
Welcome from the Chairs
This platform seeks to provide a forum for discussion for scientists from around the world to share recent developments and innovative ideas in medicinal chemistry and pharmaceutics. This will allow students, researchers, and experts to share their latest theories, results, models, and applications within this multidisciplinary area of knowledge. This is an entirely online conference that will be held in November at https://sciforum.net/event/ECMC-P2025. No registration fee will be charged to participants, and an added advantage is the lack of cost for flights, hotels, etc.
• Biomolecules, natural products, phages, and cells as therapeutic tools
• Biological targets and biomarkers
• Radiopharmaceutical sciences, radiochemistry, (hybrid) imaging, and nuclear medicine
• Nanotechnology
• Pharmacokinetics and pharmacodynamics
• Pharmaceutical preparations and drug delivery
Researchers are invited to provide a short abstract (250 words maximum without figures and references) online, through this link from now until 21 September 2025.
Event Chairs
1. Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), Porto, Portugal
2. Laboratory of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy, University of Porto, Porto, Portugal
Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA
Department of Molecular Biology, Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), Spain
Scientific Committee Members
Dr. Stefano D’Errico graduated in Chemistry in 2004 from the University of Naples Federico II, presenting an experimental thesis in organic chemistry titled “Synthesis of L-Iminosugars, Potential Glycosidase Inhibitors.” He earned his Ph.D. in Biotechnology Sciences in 2009, defending a thesis titled “Synthesis and Structural Characterization of Quadruplex-Forming Oligonucleotides and Studies on Solid-Phase Synthesis of Nucleoside and Nucleotide Analogues.” Since 2022, he has been working as tenure-track researcher at the Department of Pharmacy, University of Naples Federico II. During his doctoral and postdoctoral studies, Dr. D’Errico focused on developing innovative synthetic strategies for the preparation of small molecules inspired by marine natural products. Additionally, he specialized in the synthesis of modified nucleosides and nucleotides, as well as the solid-phase synthesis of oligonucleotides, with applications in medicinal and supramolecular chemistry. His scientific profile is demonstrated by 80 papers published in peer-reviewed international journals and participation in research projects funded by European and national grants. Additionally, he has been speaker at numerous schools and conferences on organic synthesis and is member of the editorial boards of several peer-reviewed scientific journals.
Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium
Department of Environmental Biology, Sapienza University of Rome, Rome, Italy
Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal
M. Matilde Marques was born in Santarém, Portugal. She holds B.S. and Ph.D. degrees in Chemical Engineering and a Habilitation title (D.Sc.) in Chemistry from Instituto Superior Técnico (IST), University of Lisbon, Portugal. She conducted postdoctoral work in Chemical Carcinogenesis at the FDA National Center for Toxicological Research, USA, and is currently a full professor of Organic and Medicinal Chemistry at IST, where she has coordinated the M.Sc. and Ph.D. Chemistry Programs and held multiple institutional positions. She recently served as vice-chair of IST’s Scientific Council (2017-2024). Her research focuses on the molecular mechanisms of toxicity induced by environmental (e.g.,aromatic amines, acrylamide) and therapeutic (e.g., antiestrogens, anti-HIV drugs) xenobiotics, on the development/validation of analytical methodologies for the detection and quantitation of biomarkers of exposure to toxic agents, and on the design, synthesis, and biological evaluation of potential therapeutic agents. She has served as Chair of the Division of Medicinal Chemistry of the Portuguese Chemical Society and Council Member of the European Federation for Medicinal Chemistry (2016-2020). She serves on the Editorial Board for Pharmaceuticals, has served several terms on the Editorial Advisory Board for Chemical Research in Toxicology, and has served as team-member, subgroup chair, and overall chair on multiple working groups for WHO’s International Agency for Research on Cancer.
Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, USA
Center of Health Sciences, Laboratory of Molecular Modeling and Computational Structural Biology, Federal University of Rio de Janeiro, IPPN, Rio de Janeiro, Brazil
Professor of Computational Biophysical Chemistry at the Walter Mors Natural Products Research Institute, Health Sciences Center of the Federal University of Rio de Janeiro, Brazil. B.A in Industrial Chemistry (1992); postgraduate degree (lato sensu) in Economic Engineering and Industrial Management from the Polytechnic School of the Federal University of Rio de Janeiro, Brazil (1995); M.Sc. and a Ph.D. in Computational Chemistry from the Military Institute of Engineering, where I did research with J. Daniel Figueroa-Villar, Brazil, and Anton J. Hopfinger, USA (2000). Before assuming my (tenured) position as a university professor, I worked as: chemist in Brazilian chemical, and aviation and aerospace component manufacturing companies; postdoctoral scientist at the Institute of Chemistry of the Federal University of Rio de Janeiro, Brazil; Research Specialist at The Chem21, Inc., USA; senior postdoctoral scientist at the University of Illinois at Chicago College of Pharmacy, USA; Research Associate at University of British Columbia Department of Medicine, Canada; senior scientist at the Institute of Drug Technology (Farmanguinhos)/Fiocruz; and visiting scientist at the Inflammation Laboratory of IOC/Fiocruz, Brazil. My main scientific interests are: Medicinal Chemistry; Structural Biology; Immunology; Virology; Organic Reaction Mechanisms; and Enzyme Catalysis.
Department of Pharmacognosy, Faculty of Pharmacy, Lokman Hekim University, Ankara, Türkiye
Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
Alessandra Ammazzalorso is an Associate Professor in Medicinal Chemistry at the Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara (Italy). She obtained her degree in Pharmaceutical Chemistry and Technology and Ph.D. in Pharmaceutical Sciences from the same University. Her research work is focused on the synthesis of novel compounds targeting Peroxisome Proliferator-Activated Receptors, with a special attention to the antitumor activity of their agonists and antagonists. She is also involved in the identification of enzyme inhibitors as anticancer agents. Her research activity is documented by papers in international peer reviewed journals, contributions to scientific meetings, and participation in international and national research projects. She is also a reviewer for several high-ranked medicinal chemistry journals, and she serves as an editorial board member and guest editor for international journals.
Department of Agriculture and Forestry, University of Warmia and Mazury, Olsztyn, Poland
Sessions
S2. Invited lectures
S3. General
S4. New Small molecules as drug candidates
S5. Natural Products and Biopharmaceuticals
S6. Novel and Sustainable approaches in Medicinal Chemistry
S7. Emerging technologies in drug discovery
S8. Radiopharmaceuticals
S9. Drug disposition and drug formulation
S10. Nanomedicine and Nanotechnology
S11. Formulation, Drug Delivery and Controlled Release
S12. Biopharmaceutics, Pharmacokinetics and Pharmacodynamics
Registration
The registration for ECMC-P 2025 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 31 October 2025.
Instructions for Authors
- Scholars interested in participating in the conference can submit their abstract (250 words maximum without figures and without references) online at this website until 21 September 2025.
- Based on the submitted abstract, the conference committee will conduct a pre-evaluation of whether a contribution from the authors of the abstract will be welcome for The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics. All authors will be notified by 5 October 2025 with regard to the acceptance status of their abstract.
- If the abstract is accepted for this conference, the author will be invited to prepare a full description of their work in the form of a poster, slideshow, or video at their best convenience, until the submission deadline of 12 October 2025.
- Posters must be uploaded as a PDF file using the Poster template file available at the end of this section.
- Slideshows must be uploaded as a PDF file using the PPT template file available at the end of this section.
- Flash communications (5 minutes) and communications (10-20 minutes) must be uploaded as an mp4/.webm/.ogg (max size: 250Mb) file (video) using the PPT template file available at the end of this section.
- Tips for authors: if you would like to prepare a video based on your PowerPoint presentation, you may use the "record slide" function in PowerPoint.
The presentation for accepted submission should be uploaded before 12 October 2025 via submission dashboard, for a final check and approval. Each work will be directed to the appropriate panel (posters, slideshows, flash communications, communications) by the conference organizing team.
- Length of the presentation: no more than 30 slides
- The slides should be in PDF format.
- Slide 1 (strictly one slide): Title, authors’ names, affiliation(s), email address of corresponding author, logos of the laboratory and/or institution (not mandatory).
- Slide 2 (strictly one slide): Graphical abstract; repeat the title of the presentation but avoid other text as far as possible.
- Slide 3 (strictly one slide): Abstract (max. 250 words) and 3–5 keywords, separated by semicolons.
- Slide 4 and following slides: These should contain (in the given sequence) Introduction, Results and Discussion, Conclusions.
- Last slide: Acknowledgments, and logos of sponsors (not mandatory).
- ECMC-P 2025 Slides Template should be used.
Posters will be available on this conference website during and after the event. Like papers presented on the conference, participants will be able to ask questions and comment about the posters. Posters can be presented without an accompanying proceedings paper. However, they will not be added to the proceedings of the conference.
- The poster should be in PDF format.
- The minimum size for images is 148 mm × 210 mm (horizontal × vertical) at 300 dpi.
- The content of the poster should be a comprehensive presentation of your accepted submission.
- No copyright issues with any elements in the poster
- ECMC-P 2025 Poster Template should be used.
Flash communications (3-5 minutes) and communications (15 minutes maximum) must be uploaded as an mp4/.webm/.ogg (max size: 250Mb) file (video) using the PPT template file available at the end of this section.
- Communication (15 minutes maximum).
- Flash Communications (3-5 minutes).
After the event, the participants of ECMC-P 2025 will be able to download an electronic Certificate of Attendance by logging in to your Sciforum personal account. Once you are logged-in, go to your profile and click on 'My certificates'. A list of all Sciforum events you have attended is available and you simply have to click on "Download" next to the correct event.
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
All participants will be invited to submit a full paper describing their work. The papers will be peer-reviewed and, upon acceptance, published in a Special Issue covering the event using templates provided by the conference. A 20% discount on the article processing charge will be applied.
Event Awards
The open-access, peer-reviewed journals Pharmaceuticals and Pharmaceutics will present awards totaling 1600 CHF for the Best Poster, Best Slideshow, Best Flash Communication, and Best Communication, as well as 500 CHF for the Best Invited Lecture. Additionally, one participant will be granted the opportunity to engage in a One-Day Microwave Practice/Test. All submissions will be evaluated independently of their respective sessions. Members of the Scientific Committee will be responsible for selecting the winning entries based on predefined criteria.
The Awards
Number of Awards Available: 4
The open-access peer-reviewed journals Pharmaceuticals and Pharmaceutics will provide a prize of 400 CHF for each award.
Number of Awards Available: 1
The open-access peer-reviewed journals Pharmaceuticals and Pharmaceutics will offer a 500 CHF award to the participant with the Best Invited Lecture Award.
Number of Awards Available: 1
One Day Microwave Practice/Test for free offered by Microwave Technologies Consulting. Selection will be made by the Company following strict scientific criteria.
Sponsors and Partners
Organizers
Media Partners
Conference Secretariat
Ms. Gill Tan
Ms. Adelina Platon
Email: ecmc-p@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
